0.9000EUR0.00%Mkt Cap: 18.03M $P/E: —1d ago
Biosynex SA designs, manufactures, and distributes rapid diagnostic tests to patients and healthcare professionals in France and internationally. The company develops and markets IVDs in the form of RDTs and TRODs, immun…
Industry Peers
Medical DevicesIndicators:|
Key Statistics
Company
Market Cap18.03M $
Enterprise Value75.85M $
Revenue (TTM)103.47M $
Gross Profit56.91M $
Net Income (TTM)-63.29M $
Revenue/Share5.614 USD
Last Price0.9000 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees397
CountryFR
SectorHealthcare
IndustryMedical Devices
ISINFR0011005933
Valuation
P/E (Trailing)—
P/E (Forward)1.96
PEG—
EV/EBITDA-5.12
EV/Revenue0.73
P/S0.17
P/B0.45
EPS (TTM)-4.03
EPS (Forward)0.46
52W Range
0.455040% of range1.570
52W High1.570 EUR
52W Low0.4550 EUR
Profitability
Gross Margin55.00%
Oper. Margin17.37%
EBITDA Margin-14.33%
Profit Margin-61.16%
ROE-166.59%
ROA-42.74%
Growth
Revenue Growth-5.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-6.40M $
CapEx (TTM)2.92M $
FCF Margin14.89%
FCF Yield85.43%
Net Debt57.82M $
Net Debt/EBITDA-3.90
Balance Sheet
Debt/Equity1.76
Current Ratio0.64
Quick Ratio0.33
Book Value/Sh2.001 EUR
Cash/Share0.4590 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateMay 16, 2022
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.18.43M
Float7.78M
Insiders57.60%
Institutions0.00%
Technical
SMA 500.9758 (-7.8%)
SMA 2000.7974 (+12.9%)
Beta0.83
S&P 52W Chg20.25%
Avg Vol (30d)12.73K
Avg Vol (10d)8.03K
Technical Indicators
RSI (14)46.9
MACD-0.0129
MACD Signal-0.0155
MACD Hist.+0.0026
BB Upper0.9294 EUR
BB Middle0.9024 EUR
BB Lower0.8754 EUR
BB Width5.98%
ATR (14)0.0442 EUR
Vol Ratio (20d)0.10x